ALZHEIMER'S DISEASE (INCL SUBTYPES)
Clinical trials for ALZHEIMER'S DISEASE (INCL SUBTYPES) explained in plain language.
Never miss a new study
Get alerted when new ALZHEIMER'S DISEASE (INCL SUBTYPES) trials appear
Sign up with your email to follow new studies for ALZHEIMER'S DISEASE (INCL SUBTYPES), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Can a 'Longevity' molecule reach the brain and fight Alzheimer's?
Disease control CompletedThis early-phase trial tests whether MIB-626, a drug that activates sirtuin-NAD pathways, can reach the brain and affect aging-related markers in people with mild Alzheimer's. 22 participants will take either MIB-626 or a placebo for 90 days. The study primarily checks if the dru…
Matched conditions: ALZHEIMER'S DISEASE (INCL SUBTYPES)
Phase: PHASE1, PHASE2 • Sponsor: Brigham and Women's Hospital • Aim: Disease control
Last updated Jul 03, 2026 00:00 UTC
-
New digital tool spots hidden Alzheimer's risk in routine doctor visits
Knowledge-focused CompletedThis study tested whether a digital tool that scans electronic health records could help find older adults (65+) who might have undetected mild cognitive impairment or Alzheimer's disease. Over 3,400 patients from primary care clinics were identified as high-risk by the tool. Res…
Matched conditions: ALZHEIMER'S DISEASE (INCL SUBTYPES)
Phase: NA • Sponsor: Indiana University • Aim: Knowledge-focused
Last updated Aug 06, 2026 00:00 UTC